Azenta Inc (AZTA)
52.56
+0.46
(+0.88%)
USD |
NASDAQ |
May 02, 16:00
52.55
-0.01
(-0.02%)
Pre-Market: 20:00
Azenta Cash from Operations (TTM): 70.94M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 70.94M |
September 30, 2023 | 17.49M |
June 30, 2023 | -12.79M |
March 31, 2023 | -449.48M |
December 31, 2022 | -508.68M |
September 30, 2022 | -466.05M |
June 30, 2022 | -448.57M |
March 31, 2022 | 16.18M |
December 31, 2021 | 121.74M |
September 30, 2021 | 149.86M |
June 30, 2021 | 174.54M |
March 31, 2021 | 155.86M |
December 31, 2020 | 55.85M |
September 30, 2020 | 37.87M |
June 30, 2020 | 18.72M |
March 31, 2020 | 28.61M |
December 31, 2019 | 110.38M |
September 30, 2019 | 90.90M |
June 30, 2019 | 89.45M |
March 31, 2019 | 72.77M |
December 31, 2018 | 77.01M |
September 30, 2018 | 73.96M |
June 30, 2018 | 77.60M |
March 31, 2018 | 76.35M |
December 31, 2017 | 80.73M |
Date | Value |
---|---|
September 30, 2017 | 96.22M |
June 30, 2017 | 84.82M |
March 31, 2017 | 82.47M |
December 31, 2016 | 70.63M |
September 30, 2016 | 39.55M |
June 30, 2016 | 38.36M |
March 31, 2016 | 39.14M |
December 31, 2015 | 28.32M |
September 30, 2015 | 43.73M |
June 30, 2015 | 34.91M |
March 31, 2015 | 23.08M |
December 31, 2014 | 48.34M |
September 30, 2014 | 53.78M |
June 30, 2014 | 65.09M |
March 31, 2014 | 73.30M |
December 31, 2013 | 57.75M |
September 30, 2013 | 54.39M |
June 30, 2013 | 33.10M |
March 31, 2013 | 31.08M |
December 31, 2012 | 36.04M |
September 30, 2012 | 36.04M |
June 30, 2012 | 53.00M |
March 31, 2012 | 70.43M |
December 31, 2011 | 75.08M |
September 30, 2011 | 87.65M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-508.68M
Minimum
Dec 2022
174.54M
Maximum
Jun 2021
-39.32M
Average
37.87M
Median
Sep 2020
Cash from Operations (TTM) Benchmarks
Bruker Corp | 350.10M |
Harvard Bioscience Inc | 14.03M |
Bionano Genomics Inc | -125.18M |
Akoya Biosciences Inc | -50.90M |
Singular Genomics Systems Inc | -73.65M |